Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus (DEFINE)
This study is currently recruiting participants.
Study NCT00410202
Information provided by Bristol-Myers Squibb
First Received: December 11, 2006
Last Updated: November 4, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study: